FDA Approved: SUNITINIB MALATE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved a supplemental application for SUNITINIB MALATE (sunitinib malate) filed by NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

SUPPL AP for SUNITINIB MALATE (SUNITINIB MALATE)